Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of) (TAK) earnings
Quarterly and annual TAK reports and results, each read against the price at its own news timestamp. Back to the TAK overview →
4 measured TAK earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Takeda Announces FY2026 First Quarter Results, Near-Term Launch Preparations and Pipeline Progress on Track | Press release | +0.82% | +1.23% | |
| Takeda Announces FY2025 Full Year Results and FY2026 Outlook, Highlighted by Excellent Pipeline Progress and Solid FY2025 Results | Press release | -0.19% | +3.42% | |
| Takeda Announces FY2024 Full Year Results and FY2025 Outlook Reflecting Growth & Launch Products Momentum, Strong Cash Flow Generation and Late-Stage Pipeline Progress | Press release | -1.85% | -3.78% | |
| Takeda Announces FY2023 Full Year Results and FY2024 Outlook, Affirming Commitment to Late-Stage Pipeline Development and Core Operating Profit Margin Expansion | Press release | +1.94% | +3.80% |
Keep exploring
More TAK: analyst actions → · SEC filings → · TAK overview →